You are here: Industry Insights > Shingrix

News List

GSK Singapore announces availability of Shingrix in Singapore for shingles prevention prnasia
January 10, 2022
GlaxoSmithKline (GSK) Singapore announced that a new vaccine to help protect against shingles, Shingrix, is now available in Singapore.
GSK reports £8.1 billion in Q2 sales europeanpharmaceuticalreview
August 04, 2021
GSK announces “excellent” Q2 financial performance with growth across all segments – Pharmaceuticals, Vaccines, Consumer Healthcare.
US FDA approves Shingrix to prevent shingles in immuno-compromised adults expresspharma
July 28, 2021
Shingrix, a non-live, recombinant sub-unit adjuvanted vaccine, given intramuscularly in two doses, was initially approved by FDA in 2017 for the prevention of shingles in adults 50 years of age or older.
Shingrix Approved for Shingles Prevention in Immunocompromised Adults americanpharmaceuticalreview
July 27, 2021
GlaxoSmithKline plc announced that the US FDA has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 18 years and older who are or who will be at increased risk of shingles due to ...
GSK withstands Advair generics thanks to new respiratory meds, Shingrix fiercepharma
July 28, 2019
GlaxoSmithKline's been dreading generic Advair for years, but thanks to its newer respiratory meds and the fast-launching Shingrix vaccine, the company's top line is so far managing to hold its own.
GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China fiercepharma
May 29, 2019
GlaxoSmithKline’s shingles vaccine Shingrix has continuously impressed industry watchers with its explosive growth. Now, the company has added another large market to its list: China.
As Advair generic hits, GSK looks to oncology to spur growth alongside Shingrix, HIV fiercepharma
February 24, 2019
GlaxoSmithKline had several years to prepare for the U.S. generic assault on its respiratory blockbuster Advair, offering discounts and rolling out new therapies to stay in the game.
Generic Advair will put the squeeze on GSK this year pharmaphorum
February 14, 2019
GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business....
Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there's no connection fiercepharma
January 16, 2019
Sen. Chuck Schumer is raising red flags about the shortage of GlaxoSmithKline’s ultrapopular Shingrix vaccine, blaming the government shutdown for making the situation worse.
GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019' fiercepharma
December 19, 2018
In the face of "unprecedented" demand for its shingles vaccine, GlaxoSmithKline is doing everything it can to boost supply.

Previous page 1 2 3 Next page